![Claudio Ullmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Claudio Dansky Ullmann formerly worked at Takeda Pharmaceutical Co., Ltd., as Senior Medical Director from 2012 to 2015, MaxCyte, Inc., as Chief Medical Officer, Infinity Pharmaceuticals, Inc., as Senior Vice President-Clinical Development, Avenge Bio, Inc., as Chief Medical Officer, and Context Therapeutics, Inc., as Chief Medical Officer from 2024 to 2025.
Dr. Ullmann received his graduate degree from Universidad de Buenos Aires.
Anciens postes connus de Claudio Ullmann
| Sociétés | Poste | Fin |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 10/05/2025 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Directeur Technique/Scientifique/R&D | 01/01/2015 |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Directeur Technique/Scientifique/R&D | - |
| MAXCYTE, INC. | Directeur Technique/Scientifique/R&D | - |
| INFINITY PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Claudio Ullmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
